80218 Federal Register / Vol. 85, No. 239 / Friday, December 11, 2020 / Notices 

TxDOT anticipates completing the 

study process for this proposed action 

by December 2022. 

TxDOT will issue a single Final 

Environmental Impact Statement and 

Record of Decision document pursuant 

to 23 U.S.C. 139(n)(2), unless TxDOT 

determines statutory criteria or 

practicability considerations preclude 

issuance of a combined document. 

In accordance with 23 U.S.C. 139, 

cooperating agencies, participating 

agencies, and the public will be given 

an opportunity for continued input on 

project development. A virtual public 

scoping meeting is planned to be held 

on January 19, 2021. The meeting 

materials will be posted on http://

www.drive380.com starting January 19, 

2021, and will remain available through 

February 2, 2021, which is the date the 

comment period ends. The meeting will 

be hosted online and provide an 

opportunity for the public to review and 

comment on the draft coordination plan 

and schedule, the project purpose and 

need, the range of alternatives, and 

methodologies and level of detail for 

analyzing alternatives. It will also allow 

the public an opportunity to provide 

input on any expected environmental 

impacts, anticipated permits or other 

authorizations, and any significant 

issues that should be analyzed in depth 

in the EIS. In addition to the public 

scoping meeting, a public meeting will 

be held during development of the draft 

EIS, and a public hearing will be held 

after the draft EIS is prepared. Public 

notice will be given of the time and 

place of the meeting and hearing. 

The public scoping meeting, public 

meeting, and public hearing will be 

conducted in English. If you need an 

interpreter or document translator 

because English is not your primary 

language or you have difficulty 

communicating effectively in English, 

one will be provided to you. If you have 

a disability and need assistance, special 

arrangements can be made to 

accommodate most needs. If you need 

interpretation or translation services or 

you are a person with a disability who 

requires an accommodation to 

participate in the public scoping 

meeting, please contact Mr. Patrick 

Clarke, Public Information Officer, 

Dallas District at (214) 320–4483 no 

later than 4 p.m. (central time), on 

January 14, 2021. Please be aware that 

advance notice is required as some 

services and accommodations may 

require time for the Texas Department of 

Transportation to arrange. 

The public is requested to identify in 

writing potential alternatives, 

information, and analyses relevant to 

this proposed project. Such information 

may be provided by email to Mr. 

Stephen Endres, TxDOT Project 

Manager at Stephen.Endres@txdot.gov, 

or by mail to the TxDOT Dallas District, 

4777 E. US Highway 80, Mesquite, 

Texas 75150. Such information must be 

received by February 2, 2021. 

(Catalog of Federal Domestic Assistance 

Program Number 20.205, Highway Planning 

and Construction.) 

Michael T. Leary, 

Director, Planning and Program Development, 

Federal Highway Administration. 

[FR Doc. 2020–27275 Filed 12–10–20; 8:45 am] 

BILLING CODE 4910–22–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2013–0444; FMCSA– 

2014–0212; FMCSA–2015–0320; FMCSA– 

2015–0323; FMCSA–2016–0007; FMCSA– 

2018–0054] 

Qualification of Drivers; Exemption 

Applications; Epilepsy and Seizure 

Disorders 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), DOT. 

ACTION: Notice of final disposition. 

SUMMARY: FMCSA announces its 

decision to renew exemptions for nine 

individuals from the requirement in the 

Federal Motor Carrier Safety 

Regulations (FMCSRs) that interstate 

commercial motor vehicle (CMV) 

drivers have ‘‘no established medical 

history or clinical diagnosis of epilepsy 

or any other condition which is likely 

to cause loss of consciousness or any 

loss of ability to control a CMV.’’ The 

exemptions enable these individuals 

who have had one or more seizures and 

are taking anti-seizure medication to 

continue to operate CMVs in interstate 

commerce. 

DATES: The exemptions were applicable 

on November 15, 2020. The exemptions 

expire on November 15, 2022. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, (202) 366–4001, 

fmcsamedical@dot.gov, FMCSA, 

Department of Transportation, 1200 

New Jersey Avenue SE, Room W64–224, 

Washington, DC 20590–0001. Office 

hours are from 8:30 a.m. to 5 p.m., ET, 

Monday through Friday, except Federal 

holidays. If you have questions 

regarding viewing or submitting 

material to the docket, contact Dockets 

Operations, (202) 366–9826. 

SUPPLEMENTARY INFORMATION: 

I. Public Participation 

A. Viewing Documents and Comments 

To view comments, as well as any 

documents mentioned in this notice as 

being available in the docket, go to 

http://www.regulations.gov. Insert the 

docket number, FMCSA–2013–0444, 

FMCSA–2014–0212, FMCSA–2015– 

0320, FMCSA–2015–0323, FMCSA– 

2016–0007, or FMCSA–2018–0054, in 

the keyword box, and click ‘‘Search.’’ 

Next, click the ‘‘Open Docket Folder’’ 

button and choose the document to 

review. If you do not have access to the 

internet, you may view the docket 

online by visiting Dockets Operations in 

Room W12–140 on the ground floor of 

the DOT West Building, 1200 New 

Jersey Avenue SE, Washington, DC 

20590–0001, between 9 a.m. and 5 p.m., 

ET, Monday through Friday, except 

Federal holidays. To be sure someone is 

there to help you, please call (202) 366– 

9317 or (202) 366–9826 before visiting 

Dockets Operations. 

B. Privacy Act 

In accordance with 5 U.S.C. 553(c), 

DOT solicits comments from the public 

to better inform its rulemaking process. 

DOT posts these comments, without 

edit, including any personal information 

the commenter provides, to 

www.regulations.gov, as described in 

the system of records notice (DOT/ALL– 

14 FDMS), which can be reviewed at 

www.transportation.gov/privacy. 

II. Background 

On October 28, 2020, FMCSA 

published a notice announcing its 

decision to renew exemptions for nine 

individuals from the epilepsy and 

seizure disorders prohibition in 49 CFR 

391.41(b)(8) to operate a CMV in 

interstate commerce and requested 

comments from the public (85 FR 

68405). The public comment period 

ended on November 27, 2020, and no 

comments were received. 

FMCSA has evaluated the eligibility 

of these applicants and determined that 

renewing these exemptions would 

achieve a level of safety equivalent to, 

or greater than, the level that would be 

achieved by complying with 

§ 391.41(b)(8). 

The physical qualification standard 

for drivers regarding epilepsy found in 

§ 391.41(b)(8) states that a person is 

physically qualified to drive a CMV if 

that person has no established medical 

history or clinical diagnosis of epilepsy 

or any other condition which is likely 

to cause the loss of consciousness or any 

loss of ability to control a CMV. 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 239 / Friday, December 11, 2020 / Notices 80219 

1These criteria may be found in APPENDIX A TO 

PART 391—MEDICAL ADVISORY CRITERIA, 

section H. Epilepsy: § 391.41(b)(8), paragraphs 3, 4, 

and 5, which is available on the internet at https:// 

www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/ 

CFR-2015-title49-vol5-part391-appA.pdf. 

In addition to the regulations, FMCSA 

has published advisory criteria 1 to 

assist medical examiners in determining 

whether drivers with certain medical 

conditions are qualified to operate a 

CMV in interstate commerce. 

III. Discussion of Comments 

FMCSA received no comments in this 

proceeding. 

IV. Conclusion 

Based on its evaluation of the nine 

renewal exemption applications, 

FMCSA announces its decision to 

exempt the following drivers from the 

epilepsy and seizure disorders 

prohibition in § 391.41(b)(8). 

In accordance with 49 U.S.C. 31136(e) 

and 31315(b), the following groups of 

drivers received renewed exemptions in 

the month of November and are 

discussed below. 

As of November 15, 2020, and in 

accordance with 49 U.S.C. 31136(e) and 

31315(b), the following nine individuals 

have satisfied the renewal conditions for 

obtaining an exemption from the 

epilepsy and seizure disorders 

prohibition in the FMCSRs for interstate 

CMV drivers (85 FR 68405): 

Kevin Beamon (NY) 

Joshua Cirilo (MN) 

Peter DellaRocca, Jr. (PA) 

Marvin Fender (CO) 

Donald Horst (MD) 

Chad T. Knott (MD) 

Louis Lerch (IA) 

Kyle Loney (WA) 

Curtis J. Palubicki (MN) 

The drivers were included in docket 

number FMCSA–2013–0444, FMCSA– 

2014–0212, FMCSA–2015–0320, 

FMCSA–2015–0323, FMCSA–2016– 

0007, and FMCSA–2018–0054. Their 

exemptions were applicable as of 

November 15, 2020, and will expire on 

November 15, 2022. 

In accordance with 49 U.S.C. 

31315(b), each exemption will be valid 

for 2 years from the effective date unless 

revoked earlier by FMCSA. The 

exemption will be revoked if the 

following occurs: (1) The person fails to 

comply with the terms and conditions 

of the exemption; (2) the exemption has 

resulted in a lower level of safety than 

was maintained prior to being granted; 

or (3) continuation of the exemption 

would not be consistent with the goals 

and objectives of 49 U.S.C. 31136(e) and 

31315(b). 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2020–27213 Filed 12–10–20; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2018–0136] 

Qualification of Drivers; Exemption 

Applications; Hearing 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), DOT. 

ACTION: Notice of renewal of 

exemptions; request for comments. 

SUMMARY: FMCSA announces its 

decision to renew exemptions for 10 

individuals from the hearing 

requirement in the Federal Motor 

Carrier Safety Regulations (FMCSRs) for 

interstate commercial motor vehicle 

(CMV) drivers. The exemptions enable 

these hard of hearing and deaf 

individuals to continue to operate CMVs 

in interstate commerce. 

DATES: The exemptions are applicable 

on December 16, 2020. The exemptions 

expire on December 16, 2022. 

Comments must be received on or 

before January 11, 2021. 

ADDRESSES: You may submit comments 

identified by the Federal Docket 

Management System (FDMS) Docket No. 

FMCSA–2018–0136 using any of the 

following methods: 

• Federal eRulemaking Portal: Go to 

http://www.regulations.gov/ 

docket?D=FMCSA-2018-0136. Follow 

the online instructions for submitting 

comments. 

• Mail: Dockets Operations; U.S. 

Department of Transportation, 1200 

New Jersey Avenue SE, West Building 

Ground Floor, Room W12–140, 

Washington, DC 20590–0001. 

• Hand Delivery: West Building 

Ground Floor, Room W12–140, 1200 

New Jersey Avenue SE, Washington, 

DC, between 9 a.m. and 5 p.m., ET, 

Monday through Friday, except Federal 

Holidays. 

• Fax: (202) 493–2251. 

To avoid duplication, please use only 

one of these four methods. See the 

‘‘Public Participation’’ portion of the 

SUPPLEMENTARY INFORMATION section for 

instructions on submitting comments. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Christine A. Hydock, Chief, Medical 

Programs Division, 202–366–4001, 

fmcsamedical@dot.gov, FMCSA, 

Department of Transportation, 1200 

New Jersey Avenue SE, Room W64–224, 

Washington, DC 20590–0001. Office 

hours are from 8:30 a.m. to 5 p.m., ET, 

Monday through Friday, except Federal 

holidays. If you have questions 

regarding viewing or submitting 

material to the docket, contact Dockets 

Operations, (202) 366–9826. 

SUPPLEMENTARY INFORMATION: 

I. Public Participation 

A. Submitting Comments 

If you submit a comment, please 

include the docket number for this 

notice (Docket No. FMCSA–2018–0136), 

indicate the specific section of this 

document to which each comment 

applies, and provide a reason for each 

suggestion or recommendation. You 

may submit your comments and 

material online or by fax, mail, or hand 

delivery, but please use only one of 

these means. FMCSA recommends that 

you include your name and a mailing 

address, an email address, or a phone 

number in the body of your document 

so that FMCSA can contact you if there 

are questions regarding your 

submission. 

To submit your comment online, go to 

http://www.regulations.gov/ 

docket?D=FMCSA-2018-0136. Click on 

the ‘‘Comment Now!’’ button and type 

your comment into the text box on the 

following screen. Choose whether you 

are submitting your comment as an 

individual or on behalf of a third party 

and then submit. 

If you submit your comments by mail 

or hand delivery, submit them in an 

unbound format, no larger than 81⁄2 by 

11 inches, suitable for copying and 

electronic filing. If you submit 

comments by mail and would like to 

know that they reached the facility, 

please enclose a stamped, self-addressed 

postcard or envelope. 

FMCSA will consider all comments 

and material received during the 

comment period. 

B. Viewing Documents and Comments 

To view comments, as well as any 

documents mentioned in this notice as 

being available in the docket, go to 

http://www.regulations.gov/ 

docket?D=FMCSA-2018-0136 and 

choose the document to review. If you 

do not have access to the internet, you 

may view the docket online by visiting 

Dockets Operations in Room W12–140 

on the ground floor of the DOT West 

Building, 1200 New Jersey Avenue SE, 

Washington, DC 20590–0001, between 9 

a.m. and 5 p.m., ET, Monday through 

Friday, except Federal holidays. To be 

sure someone is there to help you, 


jbell on DSKJLSW7X2PROD with NOTICES